




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Invasive Cardiovascular Angiography and Intervention</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=2d1edb86-1b6a-4771-8577-42769c4272ef</link>
        <description>Clinical Topic Feed: Invasive Cardiovascular Angiography and Intervention</description>
        <language>en</language>

        

                <item>
                    <title>JACC Journals Science at ESC Heart Failure Congress 2026</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/JACC-Journals-Science-at-ESC-Heart-Failure-Congress-2026</link>                    <description>Findings from several studies presented at ESC Heart Failure Congress 2026 in Barcelona, Spain, were simultaneously published in JACC and JACC: Heart Failure, covering topics like arrhythmic burden in cardiac amyloidosis (CA), stroke and bleeding risk in CA...</description>
                    <pubdate>1778607960000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Venous Flow, Hepatic Woe: Fontan-Associated Liver Disease</title>
<link>/Education-and-Meetings/Patient-Case-Quizzes/2026/05/05/16/43/Venous-Flow-Hepatic-Woe</link>                    <description>A 31-year-old woman with hypoplastic left heart syndrome status post extracardiac Fontan procedure presents to the clinic with worsening exercise capacity, fatigue, abdominal swelling, early satiety, weight loss, and diarrhea.</description>
                    <pubdate>1778594220000</pubdate>
                    <category>Educational Activities</category>
                </item>
                <item>
                    <title>ORBITA Analysis: Microvascular Resistance Impacts PCI Benefit</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/04/11/24/ORBITA-Analysis</link>                    <description>Patients with lower microvascular resistance (MVR) saw greater placebo-controlled benefit from PCI, according to a retrospective analysis of the ORBITA trial published April 29 in JACC: Cardiovascular Interventions.</description>
                    <pubdate>1778087340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>&#226;€&#175;Eagle&#226;€™s Eye View: PCI Vs. CABG In Patients With Unprotected Left Main CAD: NOBLE Study </title>
<link>/Latest-in-Cardiology/Articles/2026/05/06/13/43/eagles-eye-view-06may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at the NOBLE trial evaluating whether percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is best for patients with unprotected left main coronary artery disease (CAD).</description>
                    <pubdate>1778075040000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Prevalence and Outcomes of PCI Performed at Facilities Without On-Site Cardiac Surgery | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/04/11/24/Prevalence-and-Outcomes-of-PCI</link>                    <description>The number of sites providing PCI without on-site cardiac surgery (no-SOS) has doubled from 2009 to 2021, now accounting for almost one-half of PCI-capable facilities in the U.S., and risk-adjusted in-hospital outcomes for PCI by SOS status were similar, according to a Brief Report published April 28 in JACC.</description>
                    <pubdate>1777899000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Joint Statement from the Society for Cardiovascular Angiography &amp; Interventions, American College of Cardiology, and Society of Thoracic Surgeons on Aortic Valve Replacement Decision-Making</title>
<link>/Latest-in-Cardiology/Articles/2026/05/01/22/49/Joint-Statement</link>                    <description>The Society for Cardiovascular Angiography &amp; Interventions (SCAI), American College of Cardiology (ACC), and Society of Thoracic Surgeons (STS), on May 1, released the following joint statement in response to recent media coverage about Transcatheter Aortic Valve Replacement (TAVR) and Surgical Aortic Valve Replacement (SAVR):...</description>
                    <pubdate>1777679520000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Featured Jobs For May 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1777629480000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC.26 Coronary Interventional Trials</title>
<link>/Latest-in-Cardiology/Articles/2026/04/27/19/07/ACC26-Coronary-Interventional-Trials</link>                    <description>Late-breaking clinical trials presented at ACC.26 focusing on coronary interventions included several looking at intravascular guidance in complex, high-risk procedures (IVUS-CHIP), bifurcation lesions (DKCRUSH VIII), and unprotected left main PCI (OPTIMAL).</description>
                    <pubdate>1777570260000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Can Cardiorespiratory Fitness Lead to Longer Lifespans?</title>
<link>/Latest-in-Cardiology/Articles/2026/04/29/14/55/eagles-eye-view-29apr2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at endovascular therapy for post-thrombotic syndrome and how it reduces severity and improves quality of life.</description>
                    <pubdate>1777474620000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Could Site Selection Improve Representation in Coronary Stent PMA Studies?</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/04/27/14/03/Could-Site-Selection-Improve-Representation</link>                    <description>Premarket approval (PMA) studies for coronary stents were found to not fully reflect the intended-use population (IUP) due to significant underrepresentation of minority participants and modest underrepresentation of women, according to research on the enrollment implications of site selection published April 29 in JACC.</description>
                    <pubdate>1777471200000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>